Exenatide was associated with a more significant reduction in the 8-OHdG level compared with insulin at week 28 (P? ?0
Exenatide was associated with a more significant reduction in the 8-OHdG level compared with insulin at week 28 (P? ?0.01, Fig.?3e), while no significant difference was observed at week 52 (Table?2). in patients with T2DM. Methods A total of 66 patients with T2DM admitted from March 10, 2015 to June 20, 2017 in the Department…